Hyaluronate-Flt1 peptide conjugate/epirubicin micelles for theranostic application to liver cancers
Cancer theranostic systems using polymeric micelles are emerging for simultaneous diagnosis and therapy. In this work, we have developed hyaluronate (HA)-Flt1 peptide conjugate micelles encapsulating epirubicin for theranostic treatment of hepatocellular carcinoma. Intravital bioimaging without labelling and in vivo anti-tumor therapeutic effect clearly confirmed the feasibility of HA-Flt1 peptide conjugate/epirubicin micelles for target-specific theranostic treatment of liver cancers.
- Publisher
- ROYAL SOC CHEMISTRY
- Issue Date
- 2015
- Language
- English
- Article Type
- Article
- Keywords
HYALURONIC-ACID DERIVATIVES; DRUG-DELIVERY SYSTEMS; POLYMERIC MICELLES; ANTI-FLT1 PEPTIDE; CONJUGATE; DOXORUBICIN; NEOVASCULARIZATION; NANOPARTICLES; EPIRUBICIN; RECEPTOR
- Citation
RSC ADVANCES, v.5, no.60, pp.48615 - 48618
- ISSN
- 2046-2069
- Appears in Collection
- Files in This Item
- There are no files associated with this item.
This item is cited by other documents in WoS
| ⊙ Detail Information in WoSⓡ | Click to see |  |
| ⊙ Cited 5 items in WoS | Click to see citing articles in |  |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.